Abstract:Growing antibiotic resistance is causing a health care crisis, leading to an urgent need for new antibiotics to tackle serious hospital and community infections. Pleuromutilin, a naturally occurring product with moderate antibacterial activity, has a unique structure that has attracted great efforts to modify its scaffold to obtain lead compounds. Herein, we report the synthesis of a series of novel pleuromutilin derivatives with a scaffold of 4(3 H )-quinazolinone or its analogues at the C-14 side chain and investigated their in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis as well as Gram-negative bacteria ( Escherichia coli and Salmonella enterica subsp. enterica serovar pullorum ). Structure-activity relationship (SAR) studies showed that the substituents on the benzene ring of 4(3 H )-quinazolinone was not as important as the substituted position to improve antibacterial activity while the substituted groups on the N-3 position of 4(3 H )-quinazolinone had strong impact on the efficacy. The replacement of the benzene moiety of 4(3 H )-quinazolinone with other rings (pyridine, pyrrole, thiophene, or cyclopentyl) also showed high antibacterial efficacy, meaning the benzene ring was dispensable for exerting powerful antibacterial properties. In vitro pharmacokinetics investigations and cytotoxicity assays indicated that 2-mercapto-4(3 H )-quinazolinone scaffold was superior to 2-(piperazin-1-yl)quinazolin-4(3 H )-one. Among this series of pleuromutilin analogues, compound 23 with a structure of 2-mercapto-3 H -pyrrolo[2,3- d ]pyrimidin-4(7 H )-one displayed the best in vitro antibacterial activity against MRSA (MIC = 0.063 μg/mL) and low cytotoxicity to RAW 264.7 cells (IC 50 >100 μM) and was demonstrated to inhibit MRSA effectively in a mouse thigh infection model, outperforming the comparator, tiamulin.

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Modified 7-Aminocephalosporin Acid and Thioether Moiety

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Thiazole-5-Carboxamide and Thioether Moiety

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Quinazolinone and Thioether Groups

Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with a Substituted Thiadiazole Moiety As Potent Drug-Resistant Bacteria Inhibitors

Novel Pleuromutilin Derivatives with Excellent Antibacterial Activity Against Staphylococcus Aureus

Chemical Synthesis And Biological Activities Of Novel Pleuromutilin Derivatives With Substituted Amino Moiety

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives

Design, Synthesis and Antibacterial Evaluation of Pleuromutilin Derivatives

Synthesis And Biological Evaluation Of New Pleuromutilin Derivatives As Antibacterial Agents

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives Containing Aryl Urea Groups

Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation

Discovery of novel pleuromutilin derivatives as potent antibacterial agents

Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety

Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents

Design, synthesis, and antibacterial activity of pleuromutilin derivatives

Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups

Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-amino Side Chain

Study on the Structure-Activity Relations of Pleuromutilin Derivatives with an Aromatic Amide and A Thioether Group in the C-14 Side Chain

Synthesis and biological evaluation of novel pleuromutilin derivatives with nitrogen-containing heterocycles as antibacterial agents

Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents

Antibacterial activity evaluation of pleuromutilin derivatives with 4(3 H )-quinazolinone scaffold against methicillin-resistant Staphylococcus aureus